The chimera effectively delivered the associated siRNA specifically to LNCaP prostate cancer expressing PSMA cells and triggered apoptosis that resulted in cell death both in culture and in a prostrate tumor xenograft model (McNamara et al., 2006). Here, FOLH1 is linked to prostate carcinoma.